Search results
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 2 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 6 days agoNovavax (NASDAQ: NVAX) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the...
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX)
ETF DAILY NEWS· 2 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Novavax has a 1 year low of $3.53 and ...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 4 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 4 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 4 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 4 days agoNovavax, Inc.’s recently made public that its President, R&D Dubovsky Filip unloaded Company’s shares for reported $0.66 million on May 14 ’24. In the deal valued at $13.90 ...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via Yahoo Finance· 4 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Shah Capital ends campaign against Novavax board after Sanofi deal By Reuters
Investing.com· 4 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 5 days agoVaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months...